Skip to main content
SpringerLink
Log in

Pathology of Prostatic Carcinoma

  • Chapter
Carcinoma of the Prostate

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 85 Accesses

Abstract

The prostate is the largest accessory reproductive gland in the male, and exhibits a marked propensity for pathologic behavior. However, little is known about its specific function. The importance of the prostate gland to pathologists is constantly increasing. Prostate surgery is the most common surgical procedure performed on American males, most often because of prostatic hyperplasia. Radical prostatectomy is now widely used in the attempt to cure clinically localized prostate cancer. Many efforts of urologists, oncologists, and pathologists are concentrated on the diagnosis of premalignant lesions and early prostate cancer and the search for reliable prognostic parameters (Chiarodo 1991; Bostwick et al. 1992b; Ware 1994).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abrahamsson P-A, di Sant’Agnese PA (1993) Neuroendocrine cells in the human prostate gland. J Androl 14: 307–309

    PubMed  CAS  Google Scholar 

  • Abrahamsson P-A, Wadström LB, Alumets J, Falkmer S, Grimelius L (1986) Peptide-hormone-and serotonin-immunoreactive cells in normal and hyperplastic prostate glands. Pathol Res Pract 181: 675–683

    PubMed  CAS  Google Scholar 

  • Abrahamsson P-A, Wadström LB, Alumets J, Falkmer S, Grimelius L (1987) Peptide-hormone-and serotonin-immunoreactive tumour cells in carcinoma of the prostate. Pathol Res Pract 182: 298–307

    PubMed  CAS  Google Scholar 

  • Abrahamsson P-A, Falkmer S, Fäit K, Grimelius L (1989) The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an “endocrine marker”. Pathol Res Pract 185: 373–380

    PubMed  CAS  Google Scholar 

  • Adlakha H, Bostwick DG (1994) Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases. Hum Pathol 25: 135–139

    Article  PubMed  CAS  Google Scholar 

  • Allsbrook WC, Simms WW (1992) Histochemistry of the prostate. Hum Pathol 23: 297–305

    Article  PubMed  Google Scholar 

  • Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE (1993) Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 71: 3952–3965

    Article  PubMed  CAS  Google Scholar 

  • Aprikian AG, Cordon-Cardo C, Fair WR, Zhang Z-F, Bazinet M, Hamdy SM, Reuter VE (1994a) Neuroendocrine differentiation in metastatic prostate adenocarcinoma. J Urol 151: 914–919

    CAS  Google Scholar 

  • Aprikian AG, Sarkis AS, Fair WR, Zhang Z-F, Fuks Z, CordonCardo C (1994b) Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J Urol 151: 1276–1280

    CAS  Google Scholar 

  • Armas OA, Aprikian AG, Melamed J et al. (1994) Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma. Am J Surg Pathol 18: 979–991

    Article  PubMed  CAS  Google Scholar 

  • Aumüller H (1983) Morphologic and endocrine aspects of prostatic function. Prostate 4: 195–214

    Article  PubMed  Google Scholar 

  • Ayala AG, Ro JY, Babaian R, Troncosa P, Grignon DJ (1989) The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 13: 21–27

    Article  PubMed  CAS  Google Scholar 

  • Benoit G, Jardin A, Gillot C (1993) Reflections and suggestions on the nomenclature of the prostate. Surg Radiol Anat 15: 325–332

    Article  PubMed  CAS  Google Scholar 

  • Berner A, Nesland JM, Waehre H, Silke J, Fossa SD (1993) Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre-and post-treatment specimens. Br J Cancer 68: 380–384

    Article  PubMed  CAS  Google Scholar 

  • Bonkhoff H, Remberger K (1993) Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch [A] 422: 35–38

    Article  CAS  Google Scholar 

  • Bonkhoff H, Stein U, Remberger K (1993) Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virchows Arch [A] 423: 291–294

    Article  CAS  Google Scholar 

  • Bonkhoff H, Stein U, Remberger K (1994a) Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 25: 42–46

    Article  CAS  Google Scholar 

  • Bonkhoff H, Stein U, Remberger K (1994b) The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24: 114–118

    Article  CAS  Google Scholar 

  • Bookstein R, Allred D (1993) Recessive oncogenes. Cancer 71: 1179–1186

    Article  PubMed  CAS  Google Scholar 

  • Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC (1993) p53 is mutated in a subset of advanced stage prostate cancers. Cancer Res 53:3369–3373

    PubMed  CAS  Google Scholar 

  • Bostwick DG (1994a) Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer. Am J Clin Pathol 102 (Suppl 1): S31 - S37

    CAS  Google Scholar 

  • Bostwick DG (1994b) Grading prostate cancer. Am J Clin Pathol 102 (Suppl 1): S38 - S56

    CAS  Google Scholar 

  • Bostwick DG (1994c) Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 18: 796–803

    Article  CAS  Google Scholar 

  • Bostwick DG, Egbert BM, Fajardo LF (1982) Radiation injury of the normal and neoplastic prostate. Am J Surg Pathol 6: 541–551

    Article  PubMed  CAS  Google Scholar 

  • Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP (1992a) The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 70 (Suppl): 291–301

    Article  CAS  Google Scholar 

  • Bostwick DG, Montironi R, Wagle R et al. (1992b) Current and proposed biologic markers in prostate cancer, J Cell Biochem Suppl 16H: 65–67

    Article  CAS  Google Scholar 

  • Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS (1993a) Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol 24: 298–310

    Article  CAS  Google Scholar 

  • Bostwick DG, Graham SD, Napalkov P et al. (1993b) Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41: 403–411

    Article  CAS  Google Scholar 

  • Bostwick DG, Srigley J, Grignon D et al. (1993c) Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 24: 819–832

    Article  CAS  Google Scholar 

  • Bostwick DG, Dousa MK, Crawford BG, Wollan PC (1994) Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Surg Pathol 18: 1240–1246

    Article  PubMed  CAS  Google Scholar 

  • Brinkman AO, Jenster G, Kuiper GGJM et al. (1992) The human androgen receptor: structure/function relationship in normal and pathological situations. J Steroid Biochem Mol Biol 41: 361–368

    Article  Google Scholar 

  • Byar DP, Mostofi FK, Vacurg (1972) Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies examined by the step section technique. Cancer 30: 5–13

    Article  PubMed  CAS  Google Scholar 

  • Capella C, Usellini L, Buffa R, Frigerio B, Solcia E (1981) The endocrine component of prostatic carcinomas, mixed adenocarcinoma-carcinoid tumours and non-tumour prostate. Histochemical and ultrastructural identification of the endocrine cells. Histopathology 5: 175–192

    Article  PubMed  CAS  Google Scholar 

  • Casamento J, Abrahamsson P-A, Nakada SY, di Sant’Agnese PA, de Mesy Jensen KL, Cockett ATK (1992) Prognostic significance of neuroendocrine differentiation in prostatic carcinoma. J Urol 147: 332A

    Google Scholar 

  • Cher ML, Chew K, Rosenau W, Carroll PR (1995) Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression. Prostate 26: 87–93

    Article  PubMed  CAS  Google Scholar 

  • Chiarodo A (ed) (1991) National Cancer Institute roundtable on prostate cancer: future research directions. Meeting Report. Cancer Res 51: 2498–2505

    Google Scholar 

  • Chodak GW, Kranc DM, Puy LA, Tihada H, Johnson K, Chang C (1992) Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. J Urol 147: 798–803

    PubMed  CAS  Google Scholar 

  • Christensen WN, Partin AW, Walsh PC, Epstein JI (1990) Pathologic findings in clinical stage A2 prostate cancer. Relation of tumor volume, grade, and location to pathologic stage. Cancer 65: 1021–1027

    Article  PubMed  CAS  Google Scholar 

  • Christensen WN, Steinberg G, Walsh PC, Epstein JI (1991) Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer 67: 2118–2124

    Article  PubMed  CAS  Google Scholar 

  • Christopher ME, Seftel AD, Sorensen K, Resnick MI (1991) Small cell carcinoma of the genitourinary tract: an immunohistochemical, electron microscopic and clinicopathological study. J Urol 146: 382–388

    PubMed  CAS  Google Scholar 

  • Cohen MK, Arber DA, Coffield KS, Keegan GT, McClintock J, Speights VO (1994) Neuroendocrine differentiation in pro-static adenocarcinoma and its relationship to tumor progression. Cancer 74: 1899–1903

    Article  PubMed  CAS  Google Scholar 

  • Cohen RJ, Glezerson G, Haffejee Z, Afrika D (1990) Prostatic carcinoma: histological and immunohistological factors affecting prognosis. Br J Urol 66: 405–410

    Article  PubMed  CAS  Google Scholar 

  • Cunha GR, Chung LWK, Shannon JM et al. (1980) Stromalepithelial interactions in sex differentiation. Biol Reprod 22: 19–42

    Article  PubMed  CAS  Google Scholar 

  • Currin SM, Lee SE, Walther PJ (1988) Flow cytometric analysis of comedocarcinoma of the prostate: an uncommon histopathological variant of prostatic adenocarcinoma. J Urol 140: 96–100

    PubMed  CAS  Google Scholar 

  • Dauge MC, Delmas V (1987) APUD type endocrine tumour of the prostate. Incidence and prognosis in association with adenocarcinoma. Prog Clin Biol Res 243: 529–531

    Google Scholar 

  • de la Torre M, Haggman M, Brandstedt S, Busch C (1993) Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: distribution, volume and DNA ploidy. Br J Urol 72: 207–213

    PubMed  Google Scholar 

  • di Sant’Agnese PA (1992) Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. Cancer 70 (Suppl): 254–268

    Article  PubMed  Google Scholar 

  • di Sant’Agnese PA, Cockett ATK (1994) The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research. J Urol 152: 1927–1931

    PubMed  Google Scholar 

  • di Sant’Agnese PA, de Mesy Jensen KL (1984) Endocrineparacrine cells of the prostate and prostatic urethra: an ultrastructural study. Hum Pathol 15: 1034–1041

    Article  PubMed  Google Scholar 

  • di Sant’Agnese PA, de Mesy Jensen KL (1987) Neuroendocrine differentiation in prostatic adenocarcinoma. Hum Pathol 18: 849–856

    Article  PubMed  Google Scholar 

  • di Sant’Agnese PA, de Mesy Jensen KL, Churukian CJ, Agarwal MM (1985) Human prostatic endocrine-paracrine (APUD) cells. Distributional analysis with a comparison of serotonin and neuron-specific enolase immunoreactivity and silver stains. Arch Pathol Lab Med 109: 607–612

    PubMed  Google Scholar 

  • Eggleston JC, Walsh PC (1985) Radical prostatectomy with preservation of sexual function: pathologic findings in the first 100 cases. J Urol 134: 1146–1148

    PubMed  CAS  Google Scholar 

  • Elgamal AA, Van de Voorde W, Van Poppel H, Lauweryns J, Baert L (1994a) Immunohistochemical localization of prostate-specific markers within accessory male sex glands of Cowper, Littré and Morgagni. Urology 44: 84–90

    Article  CAS  Google Scholar 

  • Elgamal AA, Van de Voorde W, Van Poppel H, Vandeursen H, Baert L, Lauweryns J (1994b) Exophytic papillary prostatic duct adenocarcinoma with endometrioid features, occurring in prostatic urethra after TURP. Urology 43: 737–742

    Article  CAS  Google Scholar 

  • Epstein JI (1990) Evaluation of radical prostatectomy capsular margins of resection: the significance of margins designated as negative, closely approaching, and positive. Am J Surg Pathol 14: 626–632

    Article  PubMed  CAS  Google Scholar 

  • Epstein JI (1991) The evaluation of radical prostatectomy specimens. Therapeutic and prognostic implications. Pathol Annu 26: 159–210

    PubMed  Google Scholar 

  • Epstein JI (1992) Differential diagnosis in pathology. Urologic disorders. Igaku-Shoin, New York, pp 108–109

    Google Scholar 

  • Epstein JI (1993) Discrepancies between findings suspicious for prostate cancer at rectal examination and benign biopsy findings. Radiology 189: 657–658

    PubMed  CAS  Google Scholar 

  • Epstein JI (1995) Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol 26: 223–229

    Article  PubMed  CAS  Google Scholar 

  • Epstein JI, Lieberman PH (1985) Mucinous adenocarcinoma of the prostate gland. Am J Surg Pathol 9: 299–308

    Article  PubMed  CAS  Google Scholar 

  • Epstein JI, Carmichael M, Partin AW, Walsh PC (1993a) Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with five years follow-up. J Urol 149: 1478–1481

    CAS  Google Scholar 

  • Epstein JI, Carmichael M, Pizov G et al. (1993b) Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term follow-up. J Urol 150: 135–141

    CAS  Google Scholar 

  • Epstein JI, Pizov G, Walsh PC (1993c) Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71: 3582–3593

    Article  CAS  Google Scholar 

  • Fair WR, Aprikian A, Sogani P, Reuter V, Whitmore WF (1993) The role of neoadjuvant hormonal manipulation in localized prostate cancer. Cancer 71 (Suppl): 1031–1038

    Article  PubMed  CAS  Google Scholar 

  • Gaudin PB, Epstein JI (1994) Adenosis of the prostate. Histologic features in transurethral resection specimens. Am J Surg Pathol 18: 863–870

    Article  PubMed  CAS  Google Scholar 

  • Gleason DF (1990) Histologic grading of prostatic carcinoma. In: Bostwick DG (ed) Pathology of the prostate. Churchill Livingstone, New York, pp 83–93

    Google Scholar 

  • Gleason DF, Mellinger GT, Vacurg (1974) Prediction of prognosis for prostatic carcinoma by combined histological grading and clinical staging. J Urol 111: 58–64

    PubMed  CAS  Google Scholar 

  • Greene DR, Wheeler TM, Egawa S, Dunn JK, Scardino PT (1991) A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 146: 1069–1076

    PubMed  CAS  Google Scholar 

  • Greene DR, Fitzpatrick JM, Scardino PT (1995) Anatomy of the prostate and distribution of early prostate cancer. Semin Surg Oncol 11: 9–22

    Article  PubMed  CAS  Google Scholar 

  • Guerin D, Hasan N, Keen CE (1993) Signet ring cell differentiation in adenocarcinoma of the prostate: a study of five cases. Histopathology 22: 367–371

    Article  PubMed  CAS  Google Scholar 

  • Hall GS, Kramer CE, Epstein JI (1992) Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol 16: 315–324

    Article  PubMed  CAS  Google Scholar 

  • Harper ME, Glynne-Jones E, Goddard L et al. (1992) Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters. Prostate 20: 243–253

    Article  PubMed  CAS  Google Scholar 

  • Hedrick L, Epstein JI (1989) Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol 13: 389–396

    Article  PubMed  CAS  Google Scholar 

  • Helpap B (1985) Treated prostatic carcinoma. Histological, immunohistochemical and cell kinetic studies. Appl Pathol 3: 230–241

    PubMed  CAS  Google Scholar 

  • Hollstein M, Sidransky D, Vogelstein B, Harris C (1991) p53 mutations in human cancer. Science 253:49–53

    Article  PubMed  CAS  Google Scholar 

  • Huggins C, Hodges CV (1941) Studies on prostatic cancer. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1: 293–297

    CAS  Google Scholar 

  • Humphrey PA, Frazier HA, Vollmer RT, Paulson DF (1993) Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels. Cancer 71: 1821–1827

    Article  PubMed  CAS  Google Scholar 

  • Isaacs JT, Coffey DS (1984) Adaptation versus selection as the mechanism responsible for relapse of prostate cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res 41: 5070–5075

    Google Scholar 

  • Ittmann M, Wieczorek R, Heller P, Dave A, Provet J, Krolewski J (1994) Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas. Am J Pathol 145: 287–293

    PubMed  CAS  Google Scholar 

  • Jones EC, Young RH (1994) The differential diagnosis of pro-static carcinoma. Its distinction from premalignant and pseudocarcinomatous lesions of the prostate gland. Am J Clin Pathol 101: 48–64

    PubMed  CAS  Google Scholar 

  • Kadmon D, Thompson TC, Lynch GR, Scardino PT (1991) Elevated plasma chromogranin-A concentrations in prostatic carcinoma. J Urol 146: 358–361

    PubMed  CAS  Google Scholar 

  • Kallakury BVS, Frigge J, Ross JS, Fisher HAG, Figge HL, Jennings TA (1994) Association of p53 immunoreactivity with high Gleason tumor grade in prostatic adenocarcinoma. Hum Pathol 25: 92–97

    Article  PubMed  CAS  Google Scholar 

  • Kellokumpu-Lehtinen P, Santti R, Pelliriemi LJ (1980) Correlation of early cytodifferentiation of the human prostate and Leydig cells. Anat Res 196: 262–273

    Google Scholar 

  • Klocker H, Culig Z, Hobisch A, Cato ACB, Bartsch G (1994) Androgen receptor alterations in prostatic carcinoma. Prostate 25: 266–273

    Article  PubMed  CAS  Google Scholar 

  • Lane DP (1994) The regulation of p53 function: Steiner Award Lecture. Int J Cancer 57: 623–627

    Article  PubMed  CAS  Google Scholar 

  • Larsen WJ (1993) Development of the urogenital system. In: Larsen WJ (ed) Human embryology. Churchill Livingstone, New York, pp 235–279

    Google Scholar 

  • Lepor H, Gregerman M, Crosby R, Mostofi FK, Walsh PC (1985) Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis. J Urol 133: 207–212

    PubMed  CAS  Google Scholar 

  • Loda M, Fogt F, French FS, Posner M, Cukor B, Aretz HT, Alsaigh N (1994) Androgen receptor immunohistochemistry on paraffin-embedded tissue. Mod Pathol 7: 388–391

    PubMed  CAS  Google Scholar 

  • Masai M, Sumiya H, Akimoto S, Yatani R, Chang C, Liao S, Shimazaki J (1990) Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates. Prostate 17: 293–300

    Article  PubMed  CAS  Google Scholar 

  • Matzkin H, Soloway MS, Hardeman S (1991) Transitional cell carcinoma of the prostate. J Urol 146: 1207–1212

    PubMed  CAS  Google Scholar 

  • McNeal JE (1980) Anatomy of the prostate: an historical survey of divergent views. Prostate 1: 3–13

    Article  PubMed  CAS  Google Scholar 

  • McNeal JE (1983) The prostate gland. Morphology and pathobiology. Monogr Urol 4: 3–33

    Google Scholar 

  • McNeal JE (1988a) Normal histology of the prostate. Am J Surg Pathol 12: 619–633

    Article  CAS  Google Scholar 

  • McNeal JE (1988b) Significance of duct-acinar dysplasia in prostatic carcinogenesis. Prostate 13: 91–102

    Article  CAS  Google Scholar 

  • McNeal JE (1992) Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 23: 258–266

    Article  PubMed  CAS  Google Scholar 

  • McNeal JE, Bostwick DG (1986) Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 17: 64–71

    Article  PubMed  CAS  Google Scholar 

  • McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha ES, Stamey TA (1986) Patterns of progression in prostate cancer. Lancet 1: 60–63

    Article  PubMed  CAS  Google Scholar 

  • McNeal JE, Price HM, Redwine EA, Freiha FS, Stamey TA (1988a) Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and histological significance. J Urol 139: 61–65

    CAS  Google Scholar 

  • McNeal JE, Redwine EA, Freiha FS, Stamey TA (1988b) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12: 897–906

    Article  CAS  Google Scholar 

  • McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA (1990) Capsular penetration in prostate cancer. Significance for natural history and treatment Am J Surg Pathol 14: 240–247

    CAS  Google Scholar 

  • McNeal JE, Alroy J, Villers A, Redwine EA, Freiha FS, Stamey TA (1991) Mucinous differentiation in prostatic adenocarcinoma. Hum Pathol 22: 979–988

    Article  PubMed  CAS  Google Scholar 

  • Montie JE, Wood DP Jr, Vanderburg Medendorp S, Levin HS, Pontes JE (1990) The significance and management of transitional cell carcinoma of the prostate. Semin Urol 8: 262–268

    PubMed  CAS  Google Scholar 

  • Montironi R, Magi-Galluzzi C, Muzzonigro G, Prete E, Polito M, Fabris G (1994) Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. J Clin Pathol 47: 906–913

    Article  PubMed  CAS  Google Scholar 

  • Mostofi FK, Price EB Jr (1973) Tumors of male genital system (Fascicle 8). Atlas of tumor pathology, 2nd series. Armed Forces Institute of Pathology, Washington DC, pp 236–338

    Google Scholar 

  • Mostofi FK, Sesterhenn I, Sobin LH (1980) Histologic typing of prostate tumours. (International histological classification of tumours, no. 22). WHO, Geneva

    Google Scholar 

  • Murphy GP, Busch C, Abrahamsson P-A et al. (1994) Histopathology of localized prostate cancer. Scand J Urol Nephrol Suppl 162: 7–42

    PubMed  CAS  Google Scholar 

  • Myers RP (1991a) Anatomical variation of the superficial preprostatic veins with respect to radical retropublic prostatectomy. J Urol 145: 992–993

    CAS  Google Scholar 

  • Myers RP (1991b) Male urethral sphincteric anatomy and radical prostatectomy. Urol Clin North Am 18: 211–227

    CAS  Google Scholar 

  • Myers RP, Goellner JR, Cahill DR (1987) Prostate shape, external striated urethral sphincter and radical prostatectomy: the apical dissection. J Urol 138: 543–550

    PubMed  CAS  Google Scholar 

  • Myers RB, Oelschlager D, Srivastave S, Grizzle WE (1994) Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas. Prostate 25: 243–248

    Article  PubMed  CAS  Google Scholar 

  • Navone NM, Troncoso P, Pisters LL et al. (1993) p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85:1657–1669

    Article  PubMed  CAS  Google Scholar 

  • Oesterling JE, Hauzeur CG, Farrow GM (1992) Small cell ana-plastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. J Urol 147: 804–807

    PubMed  CAS  Google Scholar 

  • Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM (1993) The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol 17: 1252–1261

    Article  PubMed  CAS  Google Scholar 

  • Pearse AGE (1969) The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 17: 303–313

    Article  PubMed  CAS  Google Scholar 

  • Reese JH, Freiha FS, Gelb AB, Lum BL, Torti FM (1992) Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy. J Urol 147: 92–95

    PubMed  CAS  Google Scholar 

  • Reichlin S (1993) Neuroendocrine-immune interactions. N Engl J Med 329: 1246–1253

    Article  PubMed  CAS  Google Scholar 

  • Ro JY, Tetu B, Ayala AG, Ordonez NG (1987) Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases. Cancer 59: 977–982

    Article  PubMed  CAS  Google Scholar 

  • Ro JY, Ayala AG, Wishnow KI, Ordonez NG (1988a) Prostatic duct adenocarcinoma with endometrioid features: immunohistochemical and electron microscopic study. Semin Diagn Pathol 5: 301–311

    CAS  Google Scholar 

  • Ro JY, Grignon DJ, Troncoso P, Ayala AG (1988b) Mucin in prostatic adenocarcinoma. Semin Diagn Pathol 5: 273–283

    CAS  Google Scholar 

  • Ro JY, Grignon DJ, Ayala AG, Fernandez PL, Ordonez NG, Wishnow KI (1990) Mucinous adenocarcinoma of the prostate: histochemical and immunohistochemical studies. Hum Pathol 21: 593–600

    Article  PubMed  CAS  Google Scholar 

  • Ruizeveld de Winter JA, Trapman J, Brinkmann AO et al. (1990) Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry. J Pathol 161: 329–332

    Article  Google Scholar 

  • Sadi MV, Barrack ER (1993) Image analysis of androgen receptor immunostaining in metastatic prostate cancer-heterogeneity as a predictor of response to hormonal therapy. Cancer 71: 2574–2580

    Article  PubMed  CAS  Google Scholar 

  • Sadi MV, Walsh PC, Barrack ER (1991) Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer 67: 3057–3064

    Article  PubMed  CAS  Google Scholar 

  • Schmid H-P, McNeal JE (1992) An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol 16: 184–191

    Article  PubMed  CAS  Google Scholar 

  • Schröder FH, Hermanek P, Denis L et al. (1992) The TNM classification of prostate cancer. Prostate 4 (Suppl): 129–138

    Article  Google Scholar 

  • Schröder F, Tribukait B, Böcking A et al. (1994) Clinical utility of cellular DNA measurements in prostate carcinoma. Scand J Urol Nephrol Suppl 162: 51–64

    PubMed  Google Scholar 

  • Scott WW, Menon M, Walsh PC (1980) Hormonal therapy of prostatic cancer. Cancer 45 (Suppl): 1929–1936

    PubMed  CAS  Google Scholar 

  • Siiteri PK, Wilson JD (1974) Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab 38: 113–125

    Article  PubMed  CAS  Google Scholar 

  • Smith DM, Murphy WM (1994) Histologic changes in prostate carcinomas treated with leuprolide (Iuteinizing hormone-releasing hormone effect). Distinction from poor tumor differentiation. Cancer 73: 1472–1477

    Article  PubMed  CAS  Google Scholar 

  • Sogani P, Israel A, Lieberman P et al. (1985) Gleason grading of prostatic cancer: a predictor of survival. Urology 25: 223–227

    Article  PubMed  CAS  Google Scholar 

  • Spires SE, Banks ER, Davey DD, Jennings CD, Wood DP, Cibull ML (1994) Proliferating cell nuclear antigen in prostatic adenocarcinoma: correlation with established prognostic indicators. Urology 43: 660–666

    Article  PubMed  CAS  Google Scholar 

  • Stamey TA, Vang H, Hay AR, McNeal JE, Freiha FS, Redwine EA (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909–916

    Article  PubMed  CAS  Google Scholar 

  • Tarie M, Frkovic-Grazio S, Kraljic I, Kovacic K (1994) A more objective staging of advanced prostate cancer–routine recognition of malignant endocrine structures: the assessment of serum TPS, PSA, and NSE values. Prostate 24: 143–148

    Article  Google Scholar 

  • Thomas DJ, Robinson M, King P et al. (1993) p53 expression and clinical outcome in prostate cancer. Br J Urol 72:778–781

    Article  PubMed  CAS  Google Scholar 

  • Thompson SJ, Mellen K, Charlton RG, Marsh C, Robinson M, Neal DE (1992) p53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia. Br J Urol 69:609–613

    Article  PubMed  CAS  Google Scholar 

  • Ullrich SJ, Anderson CW, Mercer WE et al. (1992) The p53 tumor suppressor protein, a modulator of cell proliferation. J Biol Chem 267: 15259–15262

    PubMed  CAS  Google Scholar 

  • Van der Kwast TH, Schaller J, Ruizenveld de Winter JA, Van Vroonhoven CCJ, Mulder E, Boersma W, Trapman J (1991) Androgen receptors in endocrine therapy-resistant human prostate cancer. Int J Cancer 48: 189–193

    Article  PubMed  Google Scholar 

  • Van de Voorde WM, Baldewijns M, Lauweryns JM (1994a) Florid basal cell hyperplasia of the prostate. Histopathology 24: 341–348

    Article  Google Scholar 

  • Van de Voorde WM, Elgamal AA, Van Poppel HP, Verbeken EK, Baert LV, Lauweryns JM (1994b) Morphologic and immunohistochemical changes in prostate cancer after preoperative hormonal therapy. A comparative study of radical prostatectomies. Cancer 74: 3164–3175

    Article  Google Scholar 

  • Van de Voorde WM, Van Poppel HP, Haustermans K, Baert LV, Lauweryns JM (1994c) Mucin-secreting adenocarcinoma of the prostate with neuroendocrine differentiation and Paneth-like cells. Am J Surg Pathol 18: 200–207

    Article  Google Scholar 

  • Van de Voorde WM, Oyen RH, Van Poppel HP, Wouters K, Baert LV, Lauweryns JM (1995a) Peripherally localized benign hyperplastic nodules of the prostate. Mod Pathol 8: 46–50

    Google Scholar 

  • Van de Voorde WM, Van Poppel HP, Verbeken EK, Oyen RH, Baert LV, Lauweryns JM (1995b) Morphologic and neuroendocrine features of adenocarcinoma arising in the transition zone and in the peripheral zone of the prostate. Mod Pathol 8: 595–598

    Google Scholar 

  • Van Poppel HP, Ameye F, Oyen R, Van de Voorde WM, Baert LV (1992) Radical prostatectomy for localized prostate cancer. Eur J Surg Oncol 18: 456–462

    PubMed  Google Scholar 

  • Van Poppel HP, Ameye F, Oyen RH, Van de Voorde WM, Baert LV (1994) Accuracy of combined computerized tomography and fine needle aspiration cytology in lymph node staging of localized prostatic carcinoma. J Urol 151: 1310–1314

    PubMed  Google Scholar 

  • Vesalainen S, Lipponen P, Talja M, Syrjänen K (1995) Mitotic activity and prognosis in prostatic adenocarcinoma. Prostate 26: 80–86

    Article  PubMed  CAS  Google Scholar 

  • Villers A, McNeal JE, Redwine EA, Freiha FS, Stamey TA (1989) The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 142: 763–768

    PubMed  CAS  Google Scholar 

  • Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70:523–526

    Article  PubMed  CAS  Google Scholar 

  • Voges GE, McNeal JE, Redwine EA, Freiha FS, Stamey TA (1992) Morphological analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate. Cancer 65: 520–526

    Article  Google Scholar 

  • Walsh PC, Lepor H, Eggleston JC (1983) Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 4: 473–485

    Article  PubMed  CAS  Google Scholar 

  • Ware JL (1994) Prostate cancer progression. Implications of histopathology. Am J Pathol 145: 983–993

    PubMed  CAS  Google Scholar 

  • Weinstein MH, Epstein JI (1993) Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol 24: 624–629

    Article  PubMed  CAS  Google Scholar 

  • Wojno KJ, Epstein JI (1995) The utility of basal cell-specific anti-cytokeratin antibody (34ßE12) in the diagnosis of prostate cancer. A review of 228 cases. Am J Surg Pathol 19: 251–260

    Article  PubMed  CAS  Google Scholar 

  • Wood DP Jr, Montie JE, Pontes JE, Vanderburg Medendorp S, Levin HS (1989) Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. J Urol 141: 346–349

    PubMed  Google Scholar 

  • Xia T, Blackburn WR, Gardner WA (1990) Fetal prostate growth and development. Pediatr Pathol 10: 527–537

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University Hospitals (K.U. Leuven), Minderbroedersstraat 12, 3000, Leuven, Belgium

    W. M. Van De Voorde MD, PhD (Professor)

Authors
  1. W. M. Van De Voorde MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Southern California School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    Zbigniew Petrovich MD (Professor, Department of Radiation Oncology and Urology, Chairman, Department of Radiation Oncology) (Professor, Department of Radiation Oncology and Urology, Chairman, Department of Radiation Oncology)

  2. Department of Urology, St. Pieter’s Hospital, University of Leuven, Brusselsestraat 69, B-3000, Leuven, Belgium

    Luc Baert MD

  3. Department of Radiation Oncology and Nuclear Medicine, Medical College of Pennsylvania and Hahnemann University, 230 N. Broad Street, Philadelphia, PA, 1902-1192, USA

    Luther W. Brady MD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Van De Voorde, W.M. (1996). Pathology of Prostatic Carcinoma. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Prostate. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60956-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60956-5_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64627-0

  • Online ISBN: 978-3-642-60956-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation